Empagliflozin-induced Diabetic Ketoacidosis Unmasking a Type 1 Diabetes Diagnosis

Empagliflozin is a sodium glucose cotransporter-2 inhibitor that inhibits renal glucose reabsorption through an insulin-independent mechanism. This class of drugs is used in the management of type 2 diabetes. A 49-year-old female with type 2 diabetes treated with empagliflozin presented to the emerg...

Descripción completa

Detalles Bibliográficos
Autores principales: Ray, Gretchen M., Rodriguez, Chelsea, Schulman, Samantha M., Sarangarm, Preeyaporn, Bardack, Michelle, Bouchonville, Matthew F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: University of California Irvine, Department of Emergency Medicine publishing Western Journal of Emergency Medicine 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497210/
https://www.ncbi.nlm.nih.gov/pubmed/31061971
http://dx.doi.org/10.5811/cpcem.2019.2.41795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497210/
https://www.ncbi.nlm.nih.gov/pubmed/31061971
http://dx.doi.org/10.5811/cpcem.2019.2.41795

Ejemplares similares